Stifel Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.18M | Sell |
44,621
-8,569
| -16% | -$251K | ﹤0.01% | 2345 |
|
|
2025
Q4 | $1.54M | Buy |
53,190
+5,562
| +12% | +$167K | ﹤0.01% | 2129 |
|
|
2025
Q3 | $1.32M | Sell |
47,628
-2,076
| -4% | -$52.5K | ﹤0.01% | 2205 |
|
|
2025
Q2 | $1.21M | Buy |
49,704
+3,889
| +8% | +$85.2K | ﹤0.01% | 2202 |
|
|
2025
Q1 | $951K | Sell |
45,815
-446
| -1% | -$11.2K | ﹤0.01% | 2267 |
|
|
2024
Q4 | $1.09M | Sell |
46,261
-18,124
| -28% | -$446K | ﹤0.01% | 2196 |
|
|
2024
Q3 | $1.65M | Sell |
64,385
-1,087
| -2% | -$27.7K | ﹤0.01% | 1897 |
|
|
2024
Q2 | $1.54M | Sell |
65,472
-1,479
| -2% | -$37.3K | ﹤0.01% | 1906 |
|
|
2024
Q1 | $1.93M | Sell |
66,951
-1,322
| -2% | -$39.8K | ﹤0.01% | 1750 |
|
|
2023
Q4 | $2.24M | Buy |
68,273
+2,166
| +3% | +$58.9K | ﹤0.01% | 1586 |
|
|
2023
Q3 | $1.84M | Buy |
66,107
+233
| +0.4% | +$7.62K | ﹤0.01% | 1647 |
|
|
2023
Q2 | $2.25M | Buy |
65,874
+697
| +1% | +$21.9K | ﹤0.01% | 1551 |
|
|
2023
Q1 | $1.96M | Sell |
65,177
-3,024
| -4% | -$93.7K | ﹤0.01% | 1579 |
|
|
2022
Q4 | $1.93M | Sell |
68,201
-4,618
| -6% | -$147K | ﹤0.01% | 1550 |
|
|
2022
Q3 | $2.39M | Buy |
72,819
+7,470
| +11% | +$274K | ﹤0.01% | 1340 |
|
|
2022
Q2 | $2.06M | Buy |
65,349
+18,564
| +40% | +$649K | ﹤0.01% | 1476 |
|
|
2022
Q1 | $2.15M | Sell |
46,785
-11,099
| -19% | -$529K | ﹤0.01% | 1568 |
|
|
2021
Q4 | $3.54M | Sell |
57,884
-13,242
| -19% | -$915K | ﹤0.01% | 1253 |
|
|
2021
Q3 | $5.32M | Buy |
71,126
+3,634
| +5% | +$305K | 0.01% | 990 |
|
|
2021
Q2 | $6.24M | Sell |
67,492
-28,815
| -30% | -$2.45M | 0.01% | 903 |
|
|
2021
Q1 | $8.54M | Buy |
96,307
+37,053
| +63% | +$3.68M | 0.01% | 716 |
|
|
2020
Q4 | $5.53M | Buy |
59,254
+12,408
| +26% | +$989K | 0.01% | 836 |
|
|
2020
Q3 | $2.98M | Sell |
46,846
-6,617
| -12% | -$388K | 0.01% | 1010 |
|
|
2020
Q2 | $2.79M | Buy |
53,463
+30,156
| +129% | +$1.29M | 0.01% | 987 |
|
|
2020
Q1 | $730K | Buy |
23,307
+13,082
| +128% | +$437K | ﹤0.01% | 1621 |
|
|
2019
Q4 | $344K | Sell |
10,225
-11,434
| -53% | -$363K | ﹤0.01% | 2464 |
|
|
2019
Q3 | $643K | Buy |
21,659
+637
| +3% | +$20.7K | ﹤0.01% | 2026 |
|
|
2019
Q2 | $720K | Sell |
21,022
-30,477
| -59% | -$977K | ﹤0.01% | 1996 |
|
|
2019
Q1 | $1.69M | Buy |
51,499
+35,774
| +227% | +$1.06M | ﹤0.01% | 1338 |
|
|
2018
Q4 | $374K | Sell |
15,725
-4,275
| -21% | -$120K | ﹤0.01% | 2114 |
|
|
2018
Q3 | $670K | Buy |
20,000
+1,434
| +8% | +$45.4K | ﹤0.01% | 1937 |
|
|
2018
Q2 | $544K | Buy |
+18,566
| New | +$517K | ﹤0.01% | 1989 |
|
Other funds holding ARKG
Stifel Financial's ARKG Position: Q1 2026 in Review
Stifel Financial reduced its ARK Genomic Revolution ETF (ARKG) stake by 16% in Q1 2026, selling an estimated $251K and leaving 44,621 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2345.
Stifel Financial first reported a position in ARKG in Q2 2018 and has held it in 32 quarters since. The position peaked at $8.54M in Q1 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Stifel Financial held 44,621 shares of ARK Genomic Revolution ETF worth $1.18M as of Q1 2026.
- Stifel Financial sold 8,569 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $251K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2345 holding.
- Stifel Financial first reported a position in ARK Genomic Revolution ETF in Q2 2018 and has held it in 32 quarters since.
- Stifel Financial's ARK Genomic Revolution ETF position peaked at $8.54M in Q1 2021.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.